| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Q32 Bio Inc. | Director | Stock Option (Right to Buy) | 53,521 | $171,333 | $13.42 | 23 Oct 2025 | Direct |
| Stoke Therapeutics, Inc. | Interim Executive Chair, Director | Stock Option (Right to Buy) | 122,651 | 20 Mar 2025 | Direct | ||
| Stoke Therapeutics, Inc. | Interim Executive Chair, Director | Director Stock Option (Right to Buy) | 7,639 | 05 Jun 2024 | Direct | ||
| Akouos, Inc. | Director | Common Stock | 0 | $12.50 | 30 Nov 2022 | Direct | |
| Akouos, Inc. | Director | Stock Option (right to buy) | 0 | 01 Dec 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| QTTB | Q32 Bio Inc. | 23 Oct 2025 | 1 | $0 | 4 | Director | 27 Oct 2025, 21:16 |
| STOK | Stoke Therapeutics, Inc. | 20 Mar 2025 | 1 | $0 | 4 | Interim Executive Chair, Director | 20 Mar 2025, 18:18 |
| QTTB | Q32 Bio Inc. | 24 Feb 2025 | 4 | $0 | 4 | Director | 27 Feb 2025, 06:01 |
| STOK | Stoke Therapeutics, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:19 |
| QTTB | Q32 Bio Inc. | 25 Mar 2024 | 3 | -$6,413 | 4 | Director | 14 Aug 2024, 16:05 |
| QTTB | Homology Medicines, Inc. | 25 Mar 2024 | 1 | $0 | 4 | Director | 27 Mar 2024, 17:43 |
| STOK | Stoke Therapeutics, Inc. | 13 Feb 2024 | 2 | +$69,508 | 4 | Director | 15 Feb 2024, 16:17 |
| QTTB | Homology Medicines, Inc. | 01 Jan 2024 | 5 | -$7,445 | 4 | Director | 15 Feb 2024, 16:33 |
| QTTB | Homology Medicines, Inc. | 14 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 18:14 |
| STOK | Stoke Therapeutics, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 18:26 |
| QTTB | Homology Medicines, Inc. | 09 Jan 2023 | 1 | -$14,762 | 4 | Director | 11 Jan 2023, 15:05 |
| QTTB | Homology Medicines, Inc. | 01 Jan 2023 | 4 | $0 | 4 | Director | 04 Jan 2023, 15:36 |
| /report/000110465922124141-tzianabos-arthur-2022-11-30 | Akouos, Inc. | 30 Nov 2022 | 3 | $0 | 4 | Director | 02 Dec 2022, 15:51 |
| /report/000110465922074830-tzianabos-arthur-2022-06-23 | Akouos, Inc. | 23 Jun 2022 | 1 | $0 | 4 | Director | 27 Jun 2022, 17:04 |
| STOK | Stoke Therapeutics, Inc. | 07 Jun 2022 | 1 | $0 | 4 | Director | 08 Jun 2022, 17:00 |
| QTTB | Homology Medicines, Inc. | 24 Feb 2022 | 2 | $0 | 4 | President & CEO, Director | 28 Feb 2022, 15:05 |
| QTTB | Homology Medicines, Inc. | 01 Jan 2022 | 3 | -$20,239 | 4 | President & CEO, Director | 12 Jan 2022, 15:05 |
| /report/000110465921085755-tzianabos-arthur-2021-06-24 | Akouos, Inc. | 24 Jun 2021 | 1 | $0 | 4 | Director | 25 Jun 2021, 16:34 |
| STOK | Stoke Therapeutics, Inc. | 08 Jun 2021 | 1 | $0 | 4 | Director | 25 Jun 2021, 17:04 |